Blood pressure medication recalled nationwide. See affected drug
A nationwide medication recall affects thousands of blood pressure pill bottles following failed quality tests.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
📍 How it ended
The FDA issued a nationwide Class II recall for blood pressure medication due to dissolution and quality issues. Inventia Healthcare recalled thousands of bottles of chlorthalidone tablets, marking a second recall for the drug in three months.
Epilogue added 47d ago, after coverage quieted.
The brief
According to reports from outlets such as the New York Post, Fast Company, Newser, Democrat and Chronicle, qz.com, NBC 5 Dallas-Fort Worth, kens5.com, Black Doctor, wcnc.com, and wbbjtv.com, the product action was triggered by specific quality concerns. Specific figures regarding the affected products vary across the reporting. Some reports specify that 13,000 bottles are involved in the recall, while other coverage points to over 25,000 bottles of chlorthalidone tablets.
According to the reporting, the medication was recalled nationwide after failing FDA dissolution testing and encountering related quality issues. The manufacturer involved in the recall is identified in the coverage as Inventia Healthcare. The reports emphasize what consumers need to look out for, providing details on why the medication failed standard evaluations and prompting alerts regarding the affected drug.
As the situation develops, coverage does not yet specify long-term consequences for the manufacturer or additional regulatory actions. Readers and patients are advised by the reporting to look out for further announcements and verify specific details regarding the recalled medication.
Synthesized by PULSE from the headlines below under a strict no-invention contract. ✓ fact-checked: unsupported claims removed (89% supported) Updated 49d ago.
Quick answers
Which company is recalling the blood pressure medication?
According to coverage from qz.com, Inventia Healthcare is recalling the medication.
Why was the medication recalled?
Reports from kens5.com and wcnc.com state the medication was recalled after failing FDA dissolution testing and quality issues.
How many bottles are affected by the recall?
Coverage varies on the exact count, with some reports citing 13,000 bottles and others citing more than 25,000 bottles of chlorthalidone tablets.
Coverage (16)
- Blood pressure medication recalled nationwide under FDA’s Class II risk level WPRI.com · 49d ago
- FDA recalls 25k bottles of blood pressure meds for these products Bergen Record · 49d ago
- Blood pressure medication recalled over dissolving issue audacy.com · 49d ago
- Nationwide Recall Issued For Popular Blood Pressure Medication 97.3 KKRC · 49d ago
- FDA Recalls and Warnings: Blood Pressure Drug Recalled for Second Time in 3 Months; Some GLP-1 Pens May Contain No Medication MedShadow Foundation · 49d ago
- FDA recalls thousands more bottles of blood pressure medication due to quality issue NBC 5 Chicago · 49d ago
- Popular blood pressure drug recalled over dissolution issues New York Post · 49d ago
- 13,000 bottles of blood pressure medication are being recalled nationwide: What to look out for Fast Company · 49d ago
- Blood Pressure Drug Recalled Nationwide Newser · 49d ago
- Blood pressure medication recalled over dissolution issue. What to know Democrat and Chronicle · 49d ago
- Inventia Healthcare recalls 25,000 bottles of chlorthalidone tablets qz.com · 50d ago
- FDA recalls more than 13k bottles of blood pressure medication after quality issue NBC 5 Dallas-Fort Worth · 50d ago
- Blood pressure medication recalled nationwide after failing FDA dissolution testing kens5.com · 50d ago
- ALERT: Nationwide Recall of Blood Pressure Medication; 13,000+ Bottles Black Doctor · 50d ago
- Blood pressure medication recalled nationwide after failing FDA dissolution testing wcnc.com · 50d ago
- More than 25,000 bottles of blood pressure medication recalled. Here’s why wbbjtv.com · 50d ago
Topics
Related trends
Roche Secures First U.S. Approval for New Breast-Cancer Pill
Roche secures United States Food and Drug Administration approval for its new oral breast-cancer pill, Wilserdly.
Novo says Wegovy injection lowers BMI and obesity rates in children in trial
Novo Nordisk reports Wegovy injection reduced BMI and obesity rates in children as young as six in a clinical trial, expanding the drug's potential pediatric use.
The GLP-1 boom has a dark side
FDA orders new eye-risk warnings on a dozen GLP-1 drugs, including Ozempic and Zepbound, amid reports of vision-threatening events.
Millions of Americans are not taking their GLP-1 drugs as prescribed
Nearly half of U.S. GLP-1 users are altering prescribed dosing, with cost and side effects driving widespread non-adherence.
FDA rejects Summit’s ivonescimab, derailing US arrival of much-hyped PD-1xVEGF class
The United States Food and Drug Administration has rejected Summit Therapeutics and Akeso's lung cancer drug ivonescimab.
Costco-brand whipped cream recalled over potential presence of cleaning chemical
Costco has recalled its Kirkland Signature Heavy Whipped Cream over potential contamination with a cleaning chemical, pulling the product ahead of the Thanksgiving holiday.